Skip to main content

Table 3 School-age children: The importance of each outcome listed in the phase 2 questionnaire, as scored by clinicians and parents

From: Development of a core outcome set for clinical trials in childhood asthma: a survey of clinicians, parents, and young people

 

Clinicians (n = 43)

  

Parents (n = 27)

  

Outcome

Rank ( n /17)

Median (IQR)

Number (%) scoring outcome in top 3

Rank

Median (IQR)

Number (%) scoring outcome in top 3

Quality of Life

1

4 (3, 4)

20 (47)

2

4 (4, 4)

9 (33)

Exacerbations

2

4 (4, 4)

18 (42)

3

4 (4, 4)

9 (33)

Nocturnal symptoms

3

4 (4, 4)

16 (37)

4

4 (4, 4)

8 (30)

Normal activities

4

4 (4, 4)

12 (28)

8=

4 (4, 4)

4 (15)

Daytime symptoms

5

4 (4, 4)

11 (26)

6

4 (4, 4)

6 (22)

Death

6

4 (2, 4)

11 (26)

1

4 (4, 4)

14 (52)

Use of reliever inhaler

7

4 (3, 4)

9 (21)

10

4 (3, 4)

3 (11)

Hospital admission

8

4 (3, 4)

8 (19)

12

4 (4, 4)

2 (7)

Activity or exercise

9

4 (3, 4)

7 (16)

5

4 (3, 4)

7 (26)

Long-term adverse effect

10

4 (4, 4)

7 (16)

8=

4 (4.4)

4 (15)

School attendance

11

4 (3, 4)

7 (16)

11

4 (4, 4)

2 (7)

Parent/child global assessment of control

12

4 (3, 4)

7 (16)

14

4 (3, 4)

2 (7)

Lung function tests

13

3 (2, 3)

5 (12)

15

4 (3, 4)

1 (4)

GP/A + E attendance

14

4 (3, 4)

3 (7)

16

4 (3, 4)

0

Growth

15

4 (3, 4)

2 (5)

13

4 (3, 4)

2 (7)

Health-related problems when older

16

3 (2, 4)

0

7

4 (4, 4)

5 (19)

Short-term adverse effect

17

3 (2, 3)

0

17

4 (3, 4)

0